Peroxisomes are primarily studied in the brain, kidney, and liver due to the conspicuous tissue-specific pathology of peroxisomal biogenesis disorders. In contrast, little is known about the role of peroxisomes in other tissues such as the heart. In this meta-analysis, we explore mitochondrial and peroxisomal gene expression on RNA and protein levels in the brain, heart, kidney, and liver, focusing on lipid metabolism. Further, we evaluate a potential developmental and heart region-dependent specificity of our gene set. We find marginal expression of the enzymes for peroxisomal fatty acid oxidation in cardiac tissue in comparison to the liver or cardiac mitochondrial β-oxidation. However, the expression of peroxisome biogenesis proteins in the heart is similar to other tissues despite low levels of peroxisomal fatty acid oxidation. Strikingly, peroxisomal targeting signal type 2-containing factors and plasmalogen biosynthesis appear to play a fundamental role in explaining the essential protective and supporting functions of cardiac peroxisomes.
Keyphrases
- gene expression
- fatty acid
- systematic review
- poor prognosis
- heart failure
- left ventricular
- binding protein
- hydrogen peroxide
- oxidative stress
- white matter
- resting state
- magnetic resonance
- dna methylation
- randomized controlled trial
- magnetic resonance imaging
- drug delivery
- copy number
- small molecule
- multiple sclerosis
- cerebral ischemia
- visible light
- functional connectivity
- case control
- protein protein
- blood brain barrier
- climate change
- computed tomography
- amino acid
- subarachnoid hemorrhage